
Rituximab (500mg)
Active composition
Rituximab binds to CD20 on B-cells, inducing apoptosis and mediating antibody-dependent cellular cytotoxicity.
Medical applications
Enfiera 500mg Injection contains Rituximab, a monoclonal antibody medication that works by targeting specific cells within the immune system. It binds to particular proteins found on certain immune cells and influences their activity, helping regulate immune responses. This targeted action supports treatment approaches where controlled immune system activity is necessary. The injection is administered by a qualified healthcare professional in a medical setting to ensure proper dosing and monitoring. The treatment plan, including dosage and frequency, is determined by the healthcare provider based on individual patient requirements and medical evaluation. Regular monitoring may be recommended during treatment to assess progress and maintain safety. When used under proper medical supervision, Enfiera 500mg Injection helps support immune system regulation and contributes to comprehensive medical care.
Monoclonal antibody (mAb)
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Enfiera 500mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Enfiera 500mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Enfiera 500mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Enfiera 500mg Injection may not be needed in these patients. Please consult your doctor.
Exercise Caution
It is not known whether Enfiera 500mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Enfiera 500mg Injection in patients with liver disease. Please consult your doctor. Use of Enfiera 500mg Injection is not recommended in patients with the active liver disease or those who had viral hepatitis as it can reactivate the infection.
Regular Checkup
0 reviews for Enfiera 500mg Injection

Rituximab (500mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Rituximab binds to CD20 on B-cells, inducing apoptosis and mediating antibody-dependent cellular cytotoxicity.
Medical applications
Enfiera 500mg Injection contains Rituximab, a monoclonal antibody medication that works by targeting specific cells within the immune system. It binds to particular proteins found on certain immune cells and influences their activity, helping regulate immune responses. This targeted action supports treatment approaches where controlled immune system activity is necessary. The injection is administered by a qualified healthcare professional in a medical setting to ensure proper dosing and monitoring. The treatment plan, including dosage and frequency, is determined by the healthcare provider based on individual patient requirements and medical evaluation. Regular monitoring may be recommended during treatment to assess progress and maintain safety. When used under proper medical supervision, Enfiera 500mg Injection helps support immune system regulation and contributes to comprehensive medical care.
Monoclonal antibody (mAb)
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Enfiera 500mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Enfiera 500mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Enfiera 500mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Enfiera 500mg Injection may not be needed in these patients. Please consult your doctor.
Exercise Caution
It is not known whether Enfiera 500mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Enfiera 500mg Injection in patients with liver disease. Please consult your doctor. Use of Enfiera 500mg Injection is not recommended in patients with the active liver disease or those who had viral hepatitis as it can reactivate the infection.
Regular Checkup
0 reviews for Enfiera 500mg Injection















